My Cart (0 )
VeriPair™ NFAT Lentiviral Dual-Reporter System
Price range: $2,400.00 through $2,500.00
VeriPair™ NFAT Lentiviral Dual-Reporter System provides a branded VeriPair™ upgrade path from single TF reporter lentivirus to an integrated dual-reporter system with stronger normalization, cleaner assay logic, and premium modality options.
Have questions about this product? Our PhD-level staff is ready to assist. Email info@lipexogen.com
Available Options:
Specifications
VeriPair™ NFAT Lentiviral Dual-Reporter System
Overview
The VeriPair™ platform is LipExoGen’s integrated dual-reporter system for pathway analysis, combining a pathway-responsive experimental reporter with a constitutive internal control in the same construct. This design reduces variability from transduction efficiency, genomic integration, and cell number while supporting cleaner, more scalable assay workflows.
NFAT is measured using pathway-responsive NFAT elements driving the experimental reporter, alongside an EF1α-driven internal control cassette for normalization. This parent product groups the three VeriPair modalities: RedShift, Luciferase, and Fluorescence.
| VeriPair™ Dual-Reporter Lentivirus | |
| Blasticidin | |
| RedShift, Luciferase, Fluorescence | |
| -80°C | |
| Shipped on dry ice |
Product Data:
Advantages
- Single-construct dual-reporter design with built-in normalization.
- Premium RedShift tier enables one-step same-well luminescence on compatible instruments.
- Luciferase and fluorescence tiers provide flexible detection options across different labs and instruments.
- Direct pathway-specific analog to the corresponding TF Reporter Lentivirus source product.
Applications
- Pathway activity quantification with stronger normalization.
- Industry-friendly assay simplification and automation workflows.
- Stable line generation using the same integrated dual-reporter logic.